Women’s intimate health is closely associated with microbiome balance. Conventional antibiotics and broad-spectrum antimicrobial agents typically employ non-selective mechanisms of action. While they may provide short-term symptom relief, they can disrupt beneficial microbial flora, leading to dysbiosis and an increased risk of recurrent infections.
Accordingly, a critical technological challenge lies in selectively inhibiting pathogenic microorganisms while preserving and supporting the stability of the native lactobacillus-dominant microbiota.
Core Technology Principle
This patented ingredient is derived from metabolites secreted by natural lactic acid bacteria and is rich in naturally occurring lactic acid, probiotic-derived polysaccharides, and antimicrobial peptides.
Rather than employing an aggressive sterilization approach, its design is based on a selective modulation mechanism, supporting and maintaining intimate health without disrupting the native biological environment.